Vytrus Biotech SA (VYT) Stock Price & News

All values in EUR	2024-ж. сен.	2024-ж. дек.	2025-ж. сен.
Revenue	1,53 млн	1,53 млн	2,33 млн
Cost of goods sold	164,77 миң	164,77 миң	213,27 миң
Cost of revenue	164,77 миң	164,77 миң	213,27 миң
Research and development expenses	-	-	-
Total research and development expenses	-	-	-
Selling, general, and admin expenses	1,28 млн	1,28 млн	1,71 млн
Operating expense	1,13 млн	1,13 млн	1,35 млн
Total operating expenses	1,29 млн	1,29 млн	1,57 млн
Operating income	236,08 миң	236,08 миң	766,56 миң
Other non operating income	7,05 миң	7,05 миң	-1,87 миң
EBT including unusual items	220,68 миң	220,68 миң	760,49 миң
EBT excluding unusual items	220,49 миң	220,49 миң	760,98 миң
Income tax expense	-34,46 миң	-34,47 миң	33,13 миң
Effective tax rate	-15,62%	-15,62%	4,36%
Other operating expenses	-384,52 миң	-384,52 миң	-622,89 миң
Net income	255,14 миң	255,14 миң	727,35 миң
Net profit margin	16,69%	16,69%	31,19%
Earnings per share	-	-	-
Interest and investment income	5,86 миң	5,86 миң	16,47 миң
Interest expense	-28,28 миң	-28,28 миң	-18,70 миң
Net interest expenses	-22,42 миң	-22,42 миң	-2,23 миң
Depreciation and amortization charges	228,17 миң	228,16 миң	263,45 миң
EBITDA	330,31 миң	284,10 миң	880,59 миң
Gain or loss from assets sale	-	-	-

Ask anything